YBX1 and osteosarcoma: In vitro and in vivo experiments using specific siRNAs to inhibit YB1 expression have also inhibited the expression of cell cycle proteins D1 and A, key regulatory proteins for the G1/S phase transition of the cell cycle, thereby inhibiting the proliferation of osteosarcoma cells (79–81).